Mitochondrial Function and Pathology
Mitochondrial Function and Pathology is a research topic within Molecular Biology. Science Explorer counts 84k research works in it since 1950. 20.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the dynamics of mitochondria, the production and regulation of reactive oxygen species (ROS), and their implications in various biological processes such as aging, neurodegenerative diseases, and metabolic regulation. The papers cover topics including mitochondrial fusion and fission, oxidative stress, mitochondrial dysfunction, and the role of mitochondria in cell death.
- Mitochondria
- Reactive Oxygen Species
- Oxidative Stress
- Mitochondrial Dysfunction
- Cell Death
- Mitochondrial Fusion
- Mitochondrial Fission
- Aging
- Neurodegenerative Diseases
- Metabolic Regulation
- Research works
- 84k fractional, since 1950
- In the world top 10%
- 17k per year above
- Top-10% rate
- 20.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +7% the tick is no change
Which countries lead Mitochondrial Function and Pathology research?
By volume, the United States and China publish the most (3k and 2.4k works in 2022–2025).
By volume, 2022–2025
- 1 United States 3k works
- 2 China 2.4k works
- 3 India 490 works
- 4 Germany 485 works
- 5 United Kingdom 452 works
- 6 Japan 448 works
- 7 Italy 433 works
- 8 France 322 works
- 9 Canada 295 works
- 10 Russia 276 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Mitochondrial Function and Pathology research?
By volume in 2022–2025, University of Pennsylvania publishes the most Mitochondrial Function and Pathology research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and University College London.
By volume, 2022–2025
- 1 University of Pennsylvania United States 41 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical College China 40 works
- 3 University College London United Kingdom 38 works
- 4 University of California San Diego United States 38 works
- 5 Harvard University United States 37 works
- 6 Centre National de la Recherche Scientifique France 35 works
- 7 University of Padua Italy 35 works
- 8 University of Michigan United States 35 works
- 9 Inserm France 34 works
- 10 University of Pittsburgh United States 32 works
Who are the leading researchers in Mitochondrial Function and Pathology?
The most-cited researchers publishing on Mitochondrial Function and Pathology include Kenneth J. Livak, Vamsi K. Mootha and Gad Getz.
- 1 Kenneth J. Livak 20k citations
- 2 Vamsi K. Mootha 6.9k citations
- 3 Gad Getz 6.2k citations
- 4 Luigi Ferrucci 5.3k citations
- 5 Winfried März 5.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Mitochondrial Function and Pathology research done?
The largest centres of Mitochondrial Function and Pathology research in 2022–2025 are Beijing (China), Shanghai (China), Paris (France) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Pushchino and Oklahoma City.
Largest cities, 2022–2025
Where it is the local speciality
- PushchinoRU · 23.0 works28×
- Oklahoma CityUS · 22.3 works8.2×
Location quotient: how much more of its research is in Mitochondrial Function and Pathology than the world average.
Where is the best place to study Mitochondrial Function and Pathology?
Among universities, judged by research, Air Force Medical University, Hunan University of Traditional Chinese Medicine and China Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Air Force Medical University China | 69.2 | 41.9% | 10.2× | 19 | +50.7% |
| 2 | Hunan University of Traditional Chinese Medicine China | 62.7 | 44.7% | 12.0× | 10 | — |
| 3 | China Medical University China | 53.2 | 44.1% | 5.0× | 17 | -1.3% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 52.6 | 27.2% | 3.8× | 40 | +53.7% |
| 5 | Harvard University United States | 50.8 | 32.2% | 2.7× | 37 | -7.8% |
| 6 | Heinrich Heine University Düsseldorf Germany | 50.1 | 32.6% | 4.5× | 14 | +113.7% |
| 7 | Nanjing Medical University China | 49.9 | 36.1% | 4.5× | 24 | -15.0% |
| 8 | Sichuan University China | 49.6 | 39.1% | 1.5× | 27 | +56.9% |
| 9 | University of Padua Italy | 49.0 | 24.7% | 4.1× | 35 | +9.7% |
| 10 | University of Cambridge United Kingdom | 49.0 | 30.1% | 2.4× | 28 | +51.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Mitochondrial Function and Pathology research growing?
Output in 2018–2022 was 7% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Mitochondrial Function and Pathology.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.